These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38156540)

  • 1. [Type I Hyperprolinemia - What about the Kidney?].
    Rizzo M; Amicone M; Sellitti ML; Marino A; Sannino A; Capuano I; Pisani A
    G Ital Nefrol; 2023 Dec; 40(6):. PubMed ID: 38156540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental retardation.
    Di Rosa G; Pustorino G; Spano M; Campion D; Calabrò M; Aguennouz M; Caccamo D; Legallic S; Sgro DL; Bonsignore M; Tortorella G
    Psychiatr Genet; 2008 Feb; 18(1):40-2. PubMed ID: 18197084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I hyperprolinemia: genotype/phenotype correlations.
    Guilmatre A; Legallic S; Steel G; Willis A; Di Rosa G; Goldenberg A; Drouin-Garraud V; Guet A; Mignot C; Des Portes V; Valayannopoulos V; Van Maldergem L; Hoffman JD; Izzi C; Espil-Taris C; Orcesi S; Bonafé L; Le Galloudec E; Maurey H; Ioos C; Afenjar A; Blanchet P; Echenne B; Roubertie A; Frebourg T; Valle D; Campion D
    Hum Mutat; 2010 Aug; 31(8):961-5. PubMed ID: 20524212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and clinical features of hereditary hyperprolinemia.
    Mitsubuchi H; Nakamura K; Matsumoto S; Endo F
    Pediatr Int; 2014 Aug; 56(4):492-6. PubMed ID: 24931297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 22q11 PRODH/DGCR6 deletion is frequent in hyperprolinemic subjects but is not a strong risk factor for ASD.
    Richard AC; Rovelet-Lecrux A; Delaby E; Charbonnier C; Thiruvahindrapuram B; Hatchwell E; Eis PS; Afenjar A; Gilbert Dussardier B; Scherer SW; Betancur C; Campion D
    Am J Med Genet B Neuropsychiatr Genet; 2016 Apr; 171B(3):377-82. PubMed ID: 26978485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of PRODH mutations in Korean neonates with type I hyperprolinemia.
    Jang MA; Kim BC; Ki CS; Lee SY; Kim JW; Choi TY; Lee DH; Song J; Lee YW; Park HD
    Ann Clin Lab Sci; 2013; 43(1):31-6. PubMed ID: 23462603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inborn errors of proline metabolism.
    Mitsubuchi H; Nakamura K; Matsumoto S; Endo F
    J Nutr; 2008 Oct; 138(10):2016S-2020S. PubMed ID: 18806117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRODH mutations and hyperprolinemia in a subset of schizophrenic patients.
    Jacquet H; Raux G; Thibaut F; Hecketsweiler B; Houy E; Demilly C; Haouzir S; Allio G; Fouldrin G; Drouin V; Bou J; Petit M; Campion D; Frébourg T
    Hum Mol Genet; 2002 Sep; 11(19):2243-9. PubMed ID: 12217952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D insufficiency and schizophrenia risk: evaluation of hyperprolinemia as a mediator of association.
    Clelland JD; Read LL; Drouet V; Kaon A; Kelly A; Duff KE; Nadrich RH; Rajparia A; Clelland CL
    Schizophr Res; 2014 Jun; 156(1):15-22. PubMed ID: 24787057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome.
    Raux G; Bumsel E; Hecketsweiler B; van Amelsvoort T; Zinkstok J; Manouvrier-Hanu S; Fantini C; Brévière GM; Di Rosa G; Pustorino G; Vogels A; Swillen A; Legallic S; Bou J; Opolczynski G; Drouin-Garraud V; Lemarchand M; Philip N; Gérard-Desplanches A; Carlier M; Philippe A; Nolen MC; Heron D; Sarda P; Lacombe D; Coizet C; Alembik Y; Layet V; Afenjar A; Hannequin D; Demily C; Petit M; Thibaut F; Frebourg T; Campion D
    Hum Mol Genet; 2007 Jan; 16(1):83-91. PubMed ID: 17135275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early neurological phenotype in 4 children with biallelic PRODH mutations.
    Afenjar A; Moutard ML; Doummar D; Guët A; Rabier D; Vermersch AI; Mignot C; Burglen L; Heron D; Thioulouse E; de Villemeur TB; Campion D; Rodriguez D
    Brain Dev; 2007 Oct; 29(9):547-52. PubMed ID: 17412540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric phenotypes associated with hyperprolinemia: A systematic review.
    Namavar Y; Duineveld DJ; Both GIA; Fiksinski AM; Vorstman JAS; Verhoeven-Duif NM; Zinkstok JR
    Am J Med Genet B Neuropsychiatr Genet; 2021 Jul; 186(5):289-317. PubMed ID: 34302426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolinemia as a clue in the diagnosis of a patient with psychiatric manifestations.
    Duarte M; Afonso J; Moreira A; Antunes D; Ferreira C; Correia H; Marques M; Sequeira S
    Brain Dev; 2017 Jun; 39(6):539-541. PubMed ID: 28202261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperprolinemia is a risk factor for schizoaffective disorder.
    Jacquet H; Demily C; Houy E; Hecketsweiler B; Bou J; Raux G; Lerond J; Allio G; Haouzir S; Tillaux A; Bellegou C; Fouldrin G; Delamillieure P; Ménard JF; Dollfus S; D'Amato T; Petit M; Thibaut F; Frébourg T; Campion D
    Mol Psychiatry; 2005 May; 10(5):479-85. PubMed ID: 15494707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RENAL TUBULAR TRANSPORT OF PROLINE, HYDROXYPROLINE, AND GLYCINE IN HEALTH AND IN FAMILIAL HYPERPROLINEMIA.
    SCRIVER CR; EFRON ML; SCHAFER IA
    J Clin Invest; 1964 Mar; 43(3):374-85. PubMed ID: 14135488
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term clinical outcome, therapy and mild mitochondrial dysfunction in hyperprolinemia.
    van de Ven S; Gardeitchik T; Kouwenberg D; Kluijtmans L; Wevers R; Morava E
    J Inherit Metab Dis; 2014 May; 37(3):383-90. PubMed ID: 24173411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperprolinemia type Ⅰ caused by PRODH gene variation: 2 cases report and literature review].
    Xie ZH; Li X; Xiao MJ; Liu J; Zhang Q; Zhang ZK; Yang YL; Wang HJ; Chen YX; Zhang YD; Li DX
    Zhonghua Er Ke Za Zhi; 2023 Oct; 61(10):935-937. PubMed ID: 37803864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional consequences of PRODH missense mutations.
    Bender HU; Almashanu S; Steel G; Hu CA; Lin WW; Willis A; Pulver A; Valle D
    Am J Hum Genet; 2005 Mar; 76(3):409-20. PubMed ID: 15662599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term neuropsychiatric follow-up in hyperprolinemia type I.
    Di Rosa G; Nicotera AG; Lenzo P; Spanò M; Tortorella G
    Psychiatr Genet; 2014 Aug; 24(4):172-5. PubMed ID: 24842239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcome.
    Clelland CL; Read LL; Baraldi AN; Bart CP; Pappas CA; Panek LJ; Nadrich RH; Clelland JD
    Schizophr Res; 2011 Sep; 131(1-3):139-45. PubMed ID: 21645996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.